Arcus Biosciences
RCUS
RCUS
193 hedge funds and large institutions have $791M invested in Arcus Biosciences in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+22
Holders Change %
+12.87%
% of All Funds
2.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
62
Reduced
64
Closed
20
Calls
$3.58M
Puts
$2.31M
Net Calls
+$1.27M
Net Calls Change
-$894K
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$64.7M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$80.1M |
| 3 |
3
Goldman Sachs
New York
|
$9.7M |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$22.5M |
| 5 |
TI
5
Trexquant Investment
Stamford,
Connecticut
|
$3.85M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NYLIM
201
New York Life Investment Management
New York
| – | -$404K | -21,416 | Closed |
|
|
MAM
202
Martingale Asset Management
Boston,
Massachusetts
| – | -$374K | -19,825 | Closed |
|
203
Walleye Capital
New York
| – | -$334K | -17,691 | Closed |
|
|
EFM
204
E Fund Management
Guangzhou,
China
| – | -$303K | -16,052 | Closed |
|
205
ProShare Advisors
Bethesda,
Maryland
| – | -$205K | -10,846 | Closed |
|
|
HT
206
Headlands Technologies
Chicago,
Illinois
| – | -$59.3K | -3,139 | Closed |
|
|
MLICM
207
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$54.2K | -2,870 | Closed |
|
|
QL
208
Quarry LP
New York
| – | -$51.9K | -2,750 | Closed |
|
209
KBC Group
Brussels,
Belgium
| – | -$37K | -1,952 | Closed |
|
|
S
210
SignatureFD
Atlanta,
Georgia
| – | -$1.27K | -67 | Closed |
|
|
RAM
211
Riggs Asset Management
Dallas,
Pennsylvania
| – | -$359 | -19 | Closed |
|
|
AWM
212
Avior Wealth Management
Omaha,
Nebraska
| – | -$188 | -10 | Closed |
|